DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: new drugs

News

Biogen Wins EU Backing for Big New MS Drug Hope

22.03.2013 - European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...

News

FDA Head, Company CEOs Cheer Bumper Haul of New Drugs

26.01.2013 - Pharmaceutical industry productivity is improving as a more targeted approach to drug development yields dividends and regulators offer speedier decisions on medicines that make a...

News

Top-Selling Drugs for Ultra-Rare Diseases

03.01.2013 - Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...

News

Entering the Age of the $1 Million Medicine

03.01.2013 - The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...

News

Drug Industry Treading Water on R&D Productivity

04.12.2012 - Drug companies are becoming more efficient in hunting for new treatments, though this has yet to be reflected in improved investment returns, according to a report on Tuesday. Low...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!